Defining the molecular basis of oncogene-induced replication stress

PROJECT SUMMARY/ABSTRACT Environmental genotoxic carcinogens target numerous proto-oncogenes (and tumor-suppressor genes) to induce point mutations in key codons, leading to oncogene activation. Oncogene activation disturbs a wide range of cellular processes, including alterations in the genomic and molecular landscape of precancerous cells that

contributes to genomic instability, which accelerates chromosomal breakages, rearrangements and promotes tumorigenesis. Part of this cellular turmoil involves early deregulation of physiologic DNA replication, known as replication stress. Oncogene-induced replication stress is an early driver of genomic instability and is attributed

to a plethora of factors, most notably aberrant origin firing, replication-transcription collisions, and defective nucleotide metabolism. Despite much progress in the field, the mechanisms through which oncogenes induce replication stress, particularly in early events leading to carcinogenesis, remains poorly understood. Major gaps

in our knowledge of this process include: 1) What are the early steps that contributes to oncogene-induced replication stress in precancerous cells? and 2) How are replication stress response factors coordinated to overcome/resolve replication stress in a time-dependent manner? Research into these questions have been

hampered by limitations inherent in using traditional cancer cell lines and cell biological approaches that may or may not accurately reflect the temporal and spatial regulation of the DNA replication stress response in a more physiologically-relevant in vitro pre-cancer model. In this application, we propose to address these knowledge gaps by using cancer-relevant primary human

cells to explore how oncogene-induced replication stress can shape genome-wide replication fork initiation and termination sites, focusing on how these changes in the replication program will impact genome integrity. Furthermore, we will determine how recently discovered players in the replication stress response pathway are

regulated to subvert oncogene-induced replication stress. Deciphering the mechanisms that contribute to this early replication stress response at the genome-wide level may provide new avenues for targeted cancer treatment. The questions we address here will set the stage for future investigations that include (but are not

limited to) analyses of how environmental genotoxins may influence oncogene-induced replication stress to exacerbate genomic instability to accelerate tumorigenesis.